This study aimed to analyze the impact of poor oral function on medical expenditures among older adults. We diagnosed oral hypofunction based on dental data obtained from oral health examinations and examined its association with several annual medical expenditures. Compared to individuals without oral hypofunction, those with oral hypofunction incurred higher total, outpatient medical, inpatient medical, dental, dispensing medical, and lifestyle-related medical expenditures. Those with high medical expenditure costs were significantly more likely than those without to be 80 years old, male, with oral hypofunction, poor oral hygiene, xerostomia, poor lip closure, physical frailty, mental frailty, and subjective poor health. Logistic regression analysis indicated that oral hypofunction was significantly associated with total medical, inpatient medical, dental outpatient, dispensing medical, and lifestyle-related medical expenditures, compared to those without oral hypofunction (p < 0.05). Additionally, every increase in the number of items with declined oral function and total medical, dental, and dispensing medical expenditures increased significantly (p < 0.01). The results of this study suggest an association between oral hypofunction and several medical expenditures. The prevention and early detection of oral hypofunction would reduce not only dental but also medical expenditures by the maintenance of good health.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1038/s41598-025-85768-8 | DOI Listing |
Sci Rep
January 2025
Department of Preventive Dentistry, Kagoshima University Graduate School of Medicine and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima City, 890-8544, Japan.
This study aimed to analyze the impact of poor oral function on medical expenditures among older adults. We diagnosed oral hypofunction based on dental data obtained from oral health examinations and examined its association with several annual medical expenditures. Compared to individuals without oral hypofunction, those with oral hypofunction incurred higher total, outpatient medical, inpatient medical, dental, dispensing medical, and lifestyle-related medical expenditures.
View Article and Find Full Text PDFSupport Care Cancer
January 2025
Department of Dentistry and Oral Health, Faculty of Health, Aarhus University, Aarhus, Denmark.
Purpose: This systematic review aimed to assess the updated literature for the prevention of salivary gland hypofunction and xerostomia induced by non-surgical cancer therapies.
Methods: Electronic databases of MEDLINE/PubMed, EMBASE, and Cochrane Library were searched for randomized controlled trials (RCT) that investigated interventions to prevent salivary gland hypofunction and/or xerostomia. Literature search began from the 2010 systematic review publications from the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) up to February 2024.
Clin Cancer Res
January 2025
Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Background: The long-term effect of adipose-derived mesenchymal stromal cells (ASCs) to restore radiation-induced salivary gland hypofunction in previous head and neck cancer patients have not been validated in larger settings.
Methods: The study was the 12-months follow-up of a randomised trial, including patients with hyposalivation. Patients were randomised to receive allogeneic ASCs or placebo in the submandibular glands.
BMC Oral Health
December 2024
Clinic of General, Special Care and Geriatric Dentistry, Center for Dental Medicine, University of Zürich, Zurich, Switzerland.
Gerodontology
December 2024
Department of Removable Prosthodontics and Gerodontology, Tokyo Dental College, Tokyo, Japan.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!